Analytical Data
-
基因名
Artemin
- Application
-
别名
NBN; EVN; ENOVIN; Neublastin; Neurotrophic Factor
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q9Z0L2
-
表达区间
Ala112~Gly224
-
蛋白长度
Partial
-
分子量
16kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Artemin, a member of the glial cell line-derived neurotrophic factor (GDNF) family, plays a crucial role in the development and maintenance of the peripheral nervous system, particularly in promoting the survival and differentiation of dopaminergic neurons. First identified for its neuroprotective properties, Artemin has garnered significant interest due to its potential therapeutic applications in neurodegenerative diseases, such as Parkinson's disease, where dopaminergic neuron loss is a hallmark. The recombination of Artemin proteins in research settings allows for a deeper understanding of its biological functions and mechanisms, particularly in cellular signaling pathways. Furthermore, recombinant Artemin can be utilized in preclinical studies to assess its role in neuronal regeneration and repair, making it a candidate for developing novel treatment strategies for nerve injuries and neurodegenerative disorders. Recent advancements in biotechnological methods for producing high yields of functional recombinant proteins have enhanced research capabilities, facilitating the exploration of Artemin's effects on neuronal health and its potential for therapeutic interventions in disorders characterized by neuronal stress or degeneration. Through elucidating the mechanisms underpinning Artemin's actions, researchers aim to pave the way for innovative approaches to neuroprotection and regeneration in the nervous system.
